Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 4/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.44 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.44 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 3/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | AGXT | P21549 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL647500 | 1.00 | TRPA1 (0.48) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3813606 | 1.00 | TRPA1 (0.48) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2781956 | 0.93 | MAPT (0.43) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL23423410 | 0.93 | MAPT (0.43) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL872642 | 0.93 | MAPT (0.43) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27133457 | 0.89 | TRPA1 (0.41) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL27032735 | 0.89 | TRPA1 (0.41) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 | |
| SCHEMBL2304714 | 0.85 | TSHR (0.48) | TRPA1TSHRKMT2AMAPTALDH1A1 | |
| SCHEMBL17525899 | 0.85 | TSHR (0.48) | TRPA1TSHRKMT2AMAPTALDH1A1 | |
| SCHEMBL27902244 | 0.85 | TRPA1 (0.50) | TRPA1TSHRSLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 208 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108420842-A | A kind of sowthistle-leaf ixeris seedling preparation of antigout effect | 通化师范学院 | 2018-08-21 | — | — | CN | claimed |
| US-4746322-A | Hair dye composition and process for using the same | REPLIGEN CORPORATION (US) | 1988-05-24 | — | — | US | claimed |
| EP-0161073-A2 | Dyeing composition and its use in dyeing hair | REPLIGEN CORPORATION (US) | 1985-11-13 | — | — | EP | claimed |
| JP-7324092-A | — | — | None | — | — | JP | disclosed |
| US-20260144795-A1 | SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS | H. LUNDBECK A/S (DK) | 2026-05-28 | — | — | US | disclosed |
| US-20260137706-A1 | METHODS OF TREATING INFLAMMATORY DISEASES | INTERLINE THERAPEUTICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-12624051-B2 | Macrocyclic compounds, compositions, and methods of using thereof | GENZYME CORPORATION (US) | 2026-05-12 | — | — | US | disclosed |
| EP-4724440-A1 | METHODS OF TREATING INFLAMMATORY DISEASES | Interline Therapeutics, Inc. (US) | 2026-04-15 | — | — | EP | disclosed |
| US-20260098039-A1 | SOLID FORMS OF COMPOUND I OR SALTS THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2026-04-09 | — | — | US | disclosed |
| US-20260008786-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SCHRODINGER, LLC | 2026-01-08 | — | — | US | disclosed |
| US-20260008785-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | SCHRODINGER, LLC | 2026-01-08 | — | — | US | disclosed |
| US-4584396-A | Substituted phenoxypropionates and herbicidal compositions | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1986-04-22 | — | — | US | disclosed |
| EP-0161073-A2 | Dyeing composition and its use in dyeing hair | REPLIGEN CORPORATION (US) | 1985-11-13 | — | — | EP | disclosed |
| US-4526786-A | N-Substituted phenyl-5-aminomethyl oxazolidinones and their method of use | DELALANDE S.A. (FR) | 1985-07-02 | — | — | US | disclosed |
| US-4441913-A | PRE- AND POST-EMERGENCE | NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) | 1984-04-10 | — | — | US | disclosed |
| US-4435415-A | ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1984-03-06 | — | — | US | disclosed |
| US-4413001-A | ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1983-11-01 | — | — | US | disclosed |
| US-4348393-A | ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1982-09-07 | — | — | US | disclosed |
| US-4287351-A | USEFUL AS ANTIDEPRESSANTS | DELALANDE S.A. (FR) | 1981-09-01 | — | — | US | disclosed |
| US-3933422-A | METALLIZED DYE, ANIONIC SURFACTANT | AVON PRODUCTS, INC. (US) | 1976-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144795-A1 | SPIROMACROCYCLIC OREXIN 2 RECEPTOR AGONISTS | HCRTR2, HCRTR1, CRHR1 | TRPA1 516/4885TSHR 119/4885SLC1A3 1051/4885 |
| US-12624051-B2 | Macrocyclic compounds, compositions, and methods of using thereof | CFTR, ABCC3, ABCD3 | TRPA1 274/4885TSHR 3205/4885SLC1A3 341/4885 |
| US-20260008786-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | CFTR, ABCC3, ABCD3 | TRPA1 274/4885TSHR 3205/4885SLC1A3 341/4885 |
| US-20260008785-A1 | MACROCYCLIC COMPOUNDS, COMPOSITIONS, AND METHODS OF USING THEREOF | CFTR, ABCC3, ABCD3 | TRPA1 274/4885TSHR 3071/4885SLC1A3 340/4885 |
| US-20260137706-A1 | METHODS OF TREATING INFLAMMATORY DISEASES | NR3C1, CCR1, CXCR2 | TRPA1 2630/4885TSHR 1291/4885SLC1A3 3048/4885 |
| US-20260098039-A1 | SOLID FORMS OF COMPOUND I OR SALTS THEREOF | LDHA, SLC25A11, LDHB | TRPA1 1405/4885TSHR 2751/4885SLC1A3 764/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.